Evidence map›Paper›PMID 35633544›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2022

Breast Cancer Incidence in Kyrgyzstan: Report of 15 Years of Cancer Registry.

Asan Chokoev, Stalbek Akhunbaev, Indira Kudaibergenova, Enverbek Soodonbekov, Kuanysh Kulayev, Kadyr Ospanov, Yerlan Kuandykov, Zhansaya Telmanova, Emil Makimbetov, Nurbek Igissinov

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Asan ChokoevInternational Higher School of Medicine, Bishkek, Kyrgyzstan Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan.ORCID 0000-0002-5681-4324
Stalbek AkhunbaevInternational Higher School of Medicine, Bishkek, Kyrgyzstan Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan.ORCID 0000-0001-7762-8187
Indira KudaibergenovaInternational Higher School of Medicine, Bishkek, Kyrgyzstan.ORCID 0000-0003-3007-8127
Enverbek SoodonbekovInternational Higher School of Medicine, Bishkek, Kyrgyzstan.
Kuanysh KulayevKhoja Akhmet Yassawi International Kazakh- Turkish University, Shymkent Campus, Kazakhstan.ORCID 0000-0002-3886-7238
Kadyr OspanovKhoja Akhmet Yassawi International Kazakh- Turkish University, Shymkent Campus, Kazakhstan.ORCID 0000-0002-7180-7667
Yerlan KuandykovKhoja Akhmet Yassawi International Kazakh- Turkish University, Shymkent Campus, Kazakhstan.ORCID 0000-0002-7966-1471
Zhansaya TelmanovaKhoja Akhmet Yassawi International Kazakh- Turkish University, Shymkent Campus, Kazakhstan.ORCID 0000-0002-2364-6520
Emil MakimbetovInternational Higher School of Medicine, Bishkek, Kyrgyzstan Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan.ORCID 0000-0002-1580-3530
Nurbek IgissinovEurasian Institute for Cancer Research, Bishkek, Kyrgyzstan, Astana Medical University, Nur-Sultan, Kazakhstan, Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.ORCID 0000-0002-2517-6315
International Higher School of MedicineInternational University of Kyrgyzstan · KG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe epidemiological features of the breast cancer (BC) incidence in Kyrgyzstan were studied.

methodsThe retrospective study (2003-2017). Descriptive and analytical methods of oncoepidemiology were used. Crude (CR), age-specific (ASIR), age-standardized (ASR), equalized incidence rates and approximation were calculated. The method of drawing up a cartogram based on the determination of the standard deviation (σ) from the mean (x) was applied.

resultsDuring the study period, 7,850 new cases of BC were registered. The average annual crude and age-standardized incidence rate were 18.8±0.5 and 24.0±0.5 cases per 100,000 population of female, respectively, and their trends tended to increase (Т=+1.0%; R2=0.242 and Т=+0.2%; R2=0.015, respectively). The analysis of ASIR showed unimodal growth with a peak at 60-64 years - 85.9±4.9 cases per 100,000 population of female. ASIR trends decreased in the age groups of 40-59 years, and the most pronounced decrease was in 50-54 years (T=-1.5%; R2=0.391), in other age groups the trend increased and were most pronounced up to 30 years (T=+4.4%; R2=0.180). Trends in ASR of BС tended to grow in almost all regions, with higher levels in Osh (Т=+3.6%; R2=0.665) and Jalal-Abad (Т=+3.8%; R2=0.551) regions. The cartograms of ASR per 100,000 population of female were allocated according to the following criteria: low - up to 17.2, average - from 17.2 to 26.5, high - above 26.5. The results of the spatial analysis showed the regions with a higher levels of BC incidence rate per 100,000 population of female: Chuy (31.3), Osh city (27.1) and Bishkek city (39.2).

conclusionThe study of the epidemiological spatio-temporal features of the incidence of breast cancer is of both theoretical and practical interest and plays an important role in monitoring and evaluating anticancer activities.

Indexed as

Breast NeoplasmsAdultFemaleHumansIncidenceKyrgyzstanMiddle AgedRegistriesRetrospective Studiesbreast cancerIncidenceKyrgyzstanTrends

Identifiers

PMID35633544
PMCPMC9587886
OpenAlexW4281610776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.